Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Unsupervised Clustering of DNA Copy Number Profiles Identifies a High-Risk Subtype of Hyperdiploid Multiple Myeloma: An Mmrf Commpass Analysis

Austin Christofferson, BSc, Sheri Skerget, PhD, Jessica Aldrich, Christophe Legendre, PhD, Sara Nasser, PhD, Jennifer Yesil, Daniel Auclair, The MMRF CoMMpass Network, Sagar Lonial, Jonathan J Keats, PhD

Blood (2019) 134 (Supplement_1): 1805.

https://doi.org/10.1182/blood-2019-132152

Published: 2019

Journal Articles

Isolated Trisomy 11 in Patients with Myeloid Malignancies - Is the Prognosis Not As Grim As Previously Thought?

Jan Philipp Bewersdorf, MD, Rory M Shallis, MD, Autumn Diadamo, BS, Lohith Gowda, MD, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Thomas Prebet, MD PhD, Stephanie Halene, MD, Iris Isufi, MD, Francine M. Foss, MD, Scott F. Huntington, MD MPH, Tae Kon Kim, MD PhD, Manoj M Pillai, MD, Terri L Parker, MD, Natalia Neparidze, MD, Noffar Bar, MD, Stuart Seropian, MD, Alexa J. Siddon, MD, Amer M. Zeidan, MBBS, MHS

Blood (2019) 134 (Supplement_1): 5174.

https://doi.org/10.1182/blood-2019-127277

Published: 2019

Journal Articles

Global 3D-Epigenetic Dysregulation of Cyclin D1 and D2 Actively Controls Their Expression Pattern in Multiple Myeloma

Samrat Roy Choudhury, PhD, Cody Ashby, PhD, Ruslana G. Tytarenko, MS, Yan Wang, Purvi Patel, Katie Rose Ryan, PhD, Judith A Dent, Faith E. Davies, MD, Gareth Morgan, MD, Brian A Walker, PhD

Blood (2018) 132 (Supplement 1): 3904.

https://doi.org/10.1182/blood-2018-99-115547

Published: 2018

Journal Articles

Cytokine Receptor-like Factor 2 (CRLF2) Overexpression in Myeloid Malignancies Secondary to Multiple Isodicentric Y Chromosomes: A Novel Cytogenetic Entity?

Abhishek Mangaonkar, MD, Mrinal M. Patnaik, MDMBBS, Kathleen Kaiser-Rogers, Kathleen Waldron Rao, PhD, Kevin Halling, MD PhD, Gavin Oliver, Michelle A. Elliott, MD, Patricia Greipp, DO, Daniel L. Van Dyke, PhD

Blood (2017) 130 (Supplement 1): 1702.

https://doi.org/10.1182/blood.V130.Suppl_1.1702.1702

Published: 2017

Journal Articles

Outcomes of Autologous Transplants for Patients with Multiple Myeloma and Concurrent Multiple Plasmacytomas

Seema Naik, MD, Paul J. Shaughnessy, MD, Behyar Zoghi, MDPhD, Jose C Cruz, MD, Carlos Bachier, MD

Blood (2015) 126 (23): 1973.

https://doi.org/10.1182/blood.V126.23.1973.1973

Published: 2015

Journal Articles

Frequency, Characteristics and Prognostic Significance of RUNX1 mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified

Mi-Hyun Bae, MD PhD, Young-Uk Cho, MD PhD, Bohyun Kim, Dong Hyun Lee, Seongsoo Jang, MD PhD, Eul-Ju Seo, MD PhD, Chan-Jeoung Park, MD PhD, Dae-Young Kim, MD PhD, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD, Kyoo-Hyung Lee, MD PhD, Yoon Hwan Chang, In-Suk Kim

Blood (2015) 126 (23): 3860.

https://doi.org/10.1182/blood.V126.23.3860.3860

Published: 2015

Journal Articles

Casein Kinase 1A1 (CSNK1A1) Is Recurrently Mutated in MDS Patients with Deletion of Chromosome 5q

Blood (2014) 124 (21): 4643.

https://doi.org/10.1182/blood.V124.21.4643.4643

Published: 2014

Journal Articles

Myeloid Cell Maturation Is Disrupted By Monosomy 7 or By Gain of Additional Genetic Aberrations during Clonal Evolution in Myelodysplastic Syndromes.

Barbara Katharina Zehentner, PhD, Jevon Cutler, Luise Hartmann, MS, Krystal Johnson, MS, Richard Bennington, Wayne Fritschle, MT, Keely Ghirardelli, Lisa Broderson, PhD, Doug Chapman, Christine F Stephenson, PhD, FACMG, Monica E de Baca, MD, Timothy Singleton, MD, Denise A. Wells, MD, Michael R. Loken, PhD

Blood (2014) 124 (21): 3244.

https://doi.org/10.1182/blood.V124.21.3244.3244

Published: 2014

Journal Articles

Prognostic Significance Of TP53 mutations and Single Nucleotide Polymorphisms In Acute Myeloid Leukemia

Simon B. Zeichner, D.O., Sarah Alghamdi, M.D., Gina Elhammady, M.D., Robert Poppiti, M.D., Amilcar Castellano-Sanchez, MD

Blood (2013) 122 (21): 4971.

https://doi.org/10.1182/blood.V122.21.4971.4971

Published: 2013

Journal Articles

Cytogenetic Profile Of Multiple Myeloma In The Inner City: Clinical Presentation and Survival

Adam Goldrich, MD, Anuja Kriplani, MD, Andriane Melanthiou, MPH, Daniel Fein, MS3, Elizabeth Helzner, PhD, Arvind Babu, PhD, Jason Gonsky, MD, PhD, Olcay Batuman, MD

Blood (2013) 122 (21): 5355.

https://doi.org/10.1182/blood.V122.21.5355.5355

Published: 2013

Journal Articles

MGUS Transformation Into Multiple Myeloma In Patients With Solid Organ Transplantation

Mohamad A. Younes, MD, Jonathan D Perez, MD, Zaid Alirhayim, MD, Cesar Ochoa, MD, Ruchir Patel, MD, Vrushali S. Dabak, MD

Blood (2013) 122 (21): 5325.

https://doi.org/10.1182/blood.V122.21.5325.5325

Published: 2013

Journal Articles

Stress Hematopoiesis Reveals Abnormal Control of Self-Renewal, Lineage-Bias and Myeloid Differentiation in Mll Partial Tandem Duplication (Mll-PTD) Hematopoietic Stem/Progenitor Cells

Yue Zhang, MD, Xiaomei Yan, Goro Sashida, MD, Xinghui Zhao, PhD, Yalan Rao, PhD, Susumu Goyama, MD, PhD, Susan Whitman, PhD, Nicholas Zorko, Kelsie M. Bernot, PhD, Rajeana M. Conway, David Witte, Qianfei Wang, Daniel G Tenen, MD, Zhijian Xiao, MD, Guido Marcucci, MD, James C. Mulloy, PhD, H. Leighton Grimes, PhD, Michael A. Caligiuri, M.D., Gang Huang

Blood (2012) 120 (21): 3501.

https://doi.org/10.1182/blood.V120.21.3501.3501

Published: 2012

Journal Articles

Response Adapted Therapy Using Single Agent Lenalidomide in Older Adults with Newly Diagnosed Standard Risk Multiple Myeloma

Rachid Baz, MD, Melissa Alsina, MD, Kenneth H. Shain, MD, PhD, Jennifer Paleveda, Nancy Hillgruber, RN, Elizabeth Finley-Oliver, RN, Leonel Ochoa, MD, Taiga Nishihori, MD, William Dalton, PhD, MD, Daniel Sullivan, MD

Blood (2012) 120 (21): 4060.

https://doi.org/10.1182/blood.V120.21.4060.4060

Published: 2012

Journal Articles

TTC5, a TPR Motif Cofactor Protein Required for Myeloid Leukaemogenesis

James T Lynch, PhD, Tim Somervaille, PhD MRCP FRCPath

Blood (2011) 118 (21): 59.

https://doi.org/10.1182/blood.V118.21.59.59

Published: 2011

Journal Articles

Molecular Analysis of RAS-RAF Tyrosine-Kinase Signaling Pathway Alterations in Multiple Myeloma

Valentina Artusi, MSc, Claudia Haferlach, MD, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Vera Grossmann, MSc

Blood (2011) 118 (21): 2876.

https://doi.org/10.1182/blood.V118.21.2876.2876

Published: 2011

Journal Articles

Second Clones In Molecularly-Defined Biclonal Multiple Myeloma Are Derived From Unrelated B Cells, Can Be Present at High Frequency and Exhibit Chromosomal Abnormalities

Jitra Kriangkum, PhD, Carina Debes Marun, BSc, Sarah Motz, BSc, Andrew Belch, MD, Linda M. Pilarski, PhD

Blood (2010) 116 (21): 2981.

https://doi.org/10.1182/blood.V116.21.2981.2981

Published: 2010

Journal Articles

Minor Erythroid Response and Decreased WT1 Expression After Proteasome Inhibition by Bortezomib in Myelodysplastic Syndromes (GIMEMA MDS0104 Phase II Trial).

Massimo Breccia, MD, Roberto Latagliata, MD, Laura Cannella, MD, Ida Carmosino, MD, Enrico Gottardi, Daniela Cilloni, MD, Marco Vignetti, MD, Michelina Santopietro, MD, Marco Mancini, MD, Giuliana Alimena, MD

Blood (2009) 114 (22): 1777.

https://doi.org/10.1182/blood.V114.22.1777.1777

Published: 2009

Journal Articles

Bortezomib in Combination with Dexamethasone and Pegylated Liposomal Doxorubicin (DoVeD) Breaks Plateau Responses Following Initial Induction Therapy in Multiple Myeloma: Results of a Phase II Pilot Study.

Megan C. Manco, Tomer Mark, David S Jayabalan, Faiza Zafar, Roger Pearse, Mary Crann, John P. Leonard, Selina Chen-Kiang, Morton Coleman, Ruben Niesvizky

Blood (2009) 114 (22): 2311.

https://doi.org/10.1182/blood.V114.22.2311.2311

Published: 2009

Journal Articles

Clinical Implications of Clonal Cytogenetic Abnormalities of Aquired Aplastic Anemia.

Sung Hyun Kim, Ji Hyun Lee, Kyung A. Kwon, Suee Lee, Sung Yong Oh, Hyuk-Chan Kwon, Jin-Yeong Han, MD, Moo-Kon Song, Joo-Seop Chung, Sang-Min Lee, Young-Don Joo, Ho Sup Lee, MD, Yang Soo Kim, Hyo Jin Kim

Blood (2009) 114 (22): 4217.

https://doi.org/10.1182/blood.V114.22.4217.4217

Published: 2009

Journal Articles

Low Frequency of MLL -PTD Detected in Pediatric Acute Myeloid Leukemia Using MLPA Screening.

Brian Balgobind, MD, Iris H.I.M. Hollink, MD, Dirk Reinhardt, MD, PhD, Elisabeth R van Wering, Siebold S.N. de Graaf, MD, PhD, Andre Baruchel, MD, Jean-Michel Cayuela, PhD, Rob Pieters, Christian M Zwaan, MD, PhD, Marry M van den Heuvel-Eibrink, MD, PhD

Blood (2008) 112 (11): 1512.

https://doi.org/10.1182/blood.V112.11.1512.1512

Published: 2008

NARROW

Unsupervised Clustering of DNA Copy Number Profiles Identifies a High-Risk Subtype of Hyperdiploid Multiple Myeloma: An Mmrf Commpass Analysis

Isolated Trisomy 11 in Patients with Myeloid Malignancies - Is the Prognosis Not As Grim As Previously Thought?

Global 3D-Epigenetic Dysregulation of Cyclin D1 and D2 Actively Controls Their Expression Pattern in Multiple Myeloma

Cytokine Receptor-like Factor 2 (CRLF2) Overexpression in Myeloid Malignancies Secondary to Multiple Isodicentric Y Chromosomes: A Novel Cytogenetic Entity?

Outcomes of Autologous Transplants for Patients with Multiple Myeloma and Concurrent Multiple Plasmacytomas

Frequency, Characteristics and Prognostic Significance of RUNX1 mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified

Casein Kinase 1A1 (CSNK1A1) Is Recurrently Mutated in MDS Patients with Deletion of Chromosome 5q

Myeloid Cell Maturation Is Disrupted By Monosomy 7 or By Gain of Additional Genetic Aberrations during Clonal Evolution in Myelodysplastic Syndromes.

Prognostic Significance Of TP53 mutations and Single Nucleotide Polymorphisms In Acute Myeloid Leukemia

Cytogenetic Profile Of Multiple Myeloma In The Inner City: Clinical Presentation and Survival

MGUS Transformation Into Multiple Myeloma In Patients With Solid Organ Transplantation

Stress Hematopoiesis Reveals Abnormal Control of Self-Renewal, Lineage-Bias and Myeloid Differentiation in Mll Partial Tandem Duplication (Mll-PTD) Hematopoietic Stem/Progenitor Cells

Response Adapted Therapy Using Single Agent Lenalidomide in Older Adults with Newly Diagnosed Standard Risk Multiple Myeloma

TTC5, a TPR Motif Cofactor Protein Required for Myeloid Leukaemogenesis

Molecular Analysis of RAS-RAF Tyrosine-Kinase Signaling Pathway Alterations in Multiple Myeloma

Second Clones In Molecularly-Defined Biclonal Multiple Myeloma Are Derived From Unrelated B Cells, Can Be Present at High Frequency and Exhibit Chromosomal Abnormalities

Minor Erythroid Response and Decreased WT1 Expression After Proteasome Inhibition by Bortezomib in Myelodysplastic Syndromes (GIMEMA MDS0104 Phase II Trial).

Bortezomib in Combination with Dexamethasone and Pegylated Liposomal Doxorubicin (DoVeD) Breaks Plateau Responses Following Initial Induction Therapy in Multiple Myeloma: Results of a Phase II Pilot Study.

Clinical Implications of Clonal Cytogenetic Abnormalities of Aquired Aplastic Anemia.

Low Frequency of MLL -PTD Detected in Pediatric Acute Myeloid Leukemia Using MLPA Screening.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only